This inventor holds 2 USPTO granted patents. Top assignees: Arizona State University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2015.
Company Filing History:
1 out of 2,150 
1 out of 3,688 
Years Active: 2014-2015
Title: Qingke Kong: Innovator in Recombinant Bacterium Technology
Introduction
Qingke Kong is a notable inventor based in Tempe, AZ (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant bacteria for vaccine applications. With a total of 2 patents, his work is paving the way for advancements in immunology.
Latest Patents
Kong's latest patents include innovative inventions that focus on recombinant bacteria capable of eliciting immune responses. One of his patents encompasses a recombinant bacterium that can be used in a vaccine, along with methods for utilizing this bacterium. Another patent involves a recombinant bacterium that comprises a regulated rfaH nucleic acid, as well as a vaccine that includes this bacterium. These inventions highlight his commitment to enhancing vaccine efficacy through novel biotechnological approaches.
Career Highlights
Throughout his career, Qingke Kong has worked with prominent organizations, including the United States Department of Health and Human Services and Arizona State University. His work in these institutions has allowed him to contribute to significant research and development projects in the field of health and medicine.
Collaborations
Kong has collaborated with esteemed colleagues such as Roy Curtiss III and Javier Santander-Morales. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biotechnology.
Conclusion
Qingke Kong's contributions to recombinant bacterium technology and vaccine development are noteworthy. His patents reflect a dedication to advancing medical science and improving public health through innovative solutions.